Aspirin in Acute Deep Vein Thrombosis Treatment

Introduction to Aspirin's Limited Role

The American College of Chest Physicians recommends against using aspirin as the sole method of thromboprophylaxis or treatment in DVT patients, as anticoagulation with therapeutic-dose agents is the standard of care 1, 3.
The American Society of Hematology recommends suspending aspirin for the duration of anticoagulation therapy to reduce bleeding risk without sacrificing efficacy if a patient is already taking aspirin when DVT is diagnosed 2.

Therapeutic anticoagulation is mandatory for acute DVT, with options including rivaroxaban or LMWH bridged to warfarin, as aspirin is significantly less effective and does not adequately prevent thrombus extension or pulmonary embolism 1, 2, 3.
The CHEST guidelines explicitly recommend against using aspirin as the sole method of thromboprophylaxis or treatment in DVT patients 1, 3.

Aspirin has only one evidence-based role in DVT management: secondary prevention after completing a full course of anticoagulation for unprovoked DVT, reducing recurrent VTE risk 1, 3.
For patients with unprovoked proximal DVT or PE who decide to stop anticoagulation, the CHEST guidelines suggest aspirin over no treatment to reduce recurrent VTE risk, with a Grade 2B recommendation 1.
Aspirin reduces recurrent VTE by approximately 53 fewer events per 1,000 cases over 2-4 years compared to placebo 3.

Anticoagulants are vastly superior to aspirin for VTE prevention and treatment, with heparins reducing PE risk by about two-thirds compared to aspirin's reduction of about one-half 4.
Combining aspirin with therapeutic anticoagulation increases major bleeding risk without providing additional benefit 2.

Cancer patients with DVT require therapeutic anticoagulation, not aspirin 5, 6, 7.
Multiple myeloma patients should not use aspirin for treating established DVT, although it may be used for VTE prophylaxis in specific immunomodulatory drug regimens 5, 6.
Patients on dual antiplatelet therapy should receive mechanical prophylaxis for DVT prevention in high-risk situations, but if DVT develops, full anticoagulation is still required 4.

Acute DVT diagnosed: Start therapeutic anticoagulation immediately; suspend aspirin if patient was taking it 2.
Complete 3-12 months of anticoagulation depending on provoked vs unprovoked etiology 1.
At completion of anticoagulation for unprovoked DVT:
Never use aspirin as monotherapy for acute DVT treatment 1, 3.